ApoE isoform-specific differences in behavior and cognition associated with subchronic MPTP exposure

Area of Science:

• Neuroscience
• Genetics
• Pharmacology

Background:

• Parkinson's disease (PD) involves motor and cognitive decline, with dementia affecting up to 80% of patients.
• Prodromal symptoms, like sleep disturbances, often precede motor dysfunction in PD.
• Apolipoprotein E (ApoE) isoforms (E2, E3, E4) play a role in lipid transport and may influence neurodegenerative disease risk.

Purpose of the Study:

• To investigate the influence of apolipoprotein E4 (E4) on early, preclinical changes in a mouse model of Parkinson's disease (PD).
• To determine if E4 expression exacerbates behavioral and cognitive deficits induced by the neurotoxin MPTP.

Main Methods:

• Young male and female mice expressing human E3 or E4 isoforms were administered the neurotoxin MPTP or saline.
• Behavioral tests included novel object recognition and the Morris water maze to assess cognitive function and motor activity.

Main Results:

• MPTP-treated E4 mice showed altered exploration of novel objects compared to controls.
• MPTP-treated E3 mice exhibited impaired object recognition, unlike saline-treated E3 mice.
• MPTP exposure affected swim speed in E4 mice but not in E3 mice during the water maze task.

Conclusions:

• Apolipoprotein E4 carriage may influence the manifestation of preclinical symptoms in Parkinson's disease.
• These findings highlight the potential role of ApoE isoforms in the early stages of PD.
• Further research focusing on early time points in this PD model is warranted.